Stock 600781 FUREN GROUP PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News FUREN Group Pharmaceutical Co.,Ltd.

Equities

600781

CNE000000NM4

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
FUREN Group Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
FUREN Group Pharmaceutical Co., Ltd. Appoints Zhu Wenliang as General Manager
CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
FUREN Group Pharmaceutical Co., Ltd. Elects Huang Dianying as Independent Director
CI
FUREN Group Pharmaceutical Co., Ltd.(SHSE:600781) dropped from Shanghai Stock Exchange Health Care Sector Index
CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019
CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019
CI
Shanghai Furen Industrial Co., Ltd Announces Cash Dividend for the Year 2018, Payable on July 22, 2019
CI
FUREN Group Pharmaceutical Co., Ltd.(SHSE:600781) added to Shanghai Stock Exchange Health Care Sector Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600781 Stock
  4. News FUREN Group Pharmaceutical Co.,Ltd.